黄疸的评估

Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109:950-966.

• 全文
• 摘要

1.  Greenberger NJ. History taking and physical examination for the patient with liver disease. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. 9th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2003:3-5.

2.  Poles MA, Lew EA, Dieterich DT. Diagnosis and treatment of hepatic disease in patients with HIV. Gastroenterol Clin North Am. 1997;26:291-321.

• 摘要

3.  Galan MV, Potts JA, Silverman AL, et al. The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center. J Clin Gastroenterol. 2005;39:64-67. [Published correction appears in J Clin Gastroenterol. 2005;39:176.]

• 摘要

4.  Marti L, Del Olmo JA, Ornia E, et al. Clinical evaluation of drug-induced hepatitis. Rev Esp Enferm Dig. 2005;97:258-265.

• 摘要

5.  Meier Y, Cavallaro M, Roos M, et al. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61:135-143.

• 摘要

6.  Pendino GM, Mariano A, Surace P, et al. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology. 2005;41:1151-1159.

• 全文
• 摘要

7.  Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512-521.

• 摘要

8.  Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug induced liver disease. Hepatology. 2005;42:481-489.

• 摘要

9.  Kelly P, Patchett S, McCloskey D, et al. Sclerosing cholangitis, race and sex. Gut. 1997;41:688-689.

• 摘要

10.  Tobias R, Wright J, Kottler R, et al. Primary sclerosing cholangitis associated with inflammatory bowel disease in Cape Town, 1975-1981. S Afr Med J. 1981;63:229-235.

• 摘要

11.  Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109:950-966.

• 全文
• 摘要

12.  Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-864.

• 全文
• 摘要

13.  Björnsson E, Chari ST, Smyrk TC, et al. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology. 2007;45:1547-1554.

• 全文
• 摘要

14.  Thursz MR, Richardson P, Allison M, et al; STOPAH trial. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619-1628.

• 全文
• 摘要

15.  Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-1907.

• 摘要

16.  Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54:1174-1179.

• 全文
• 摘要

17.  Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193-199.

• 摘要

18.  Dorn L, Finkelstedt A, Schranz M, et al. Immunoglobulin subclass 4 for the diagnosis of immunoglobulin subclass 4-associated diseases in an unselected liver and pancreas clinic population. HPB (Oxford). 2012;24:122-125.

• 全文
• 摘要

19.  American College of Radiology. ACR Appropriateness Criteria: jaundice. 2012. http://www.acr.org/ (last accessed 7 December 2016).

• 全文

20.  Child CG. The liver and portal hypertension. Philadelphia, PA: WB Saunders; 1964:50-72.